MedTrace Logo

Cardiovascular Complications of Sickle Cell Disease

NCT01044901 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2022-02-23

Study results available
· View outcomes & findings →

Summary

In this research study, we are using heart imaging exams and blood testing, in order to gain an improved understanding of the pulmonary (lung) hypertension and cardiovascular (heart) complications that often occur in sickle cell patients. Information gathered from the healthy volunteers that participate in this study will be compared to information from the sickle cell patients in this study in order to help further our understanding.

Conditions

Interventions

PROCEDURE

MRI, Transthoracic Echocardiography, tonometry, EKG

Unless contraindicated, subjects will receive Regadenoson and Gadolinium contrast agent during the Cardiac magnetic resonance. The tonometer, EKG, and echo are non-invasive procedures.

Sponsors & Collaborators

  • University of Chicago

    lead OTHER

Principal Investigators

  • Amit R Patel, M.D. · University of Chicago

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2021-02-28
Completion
2021-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01044901 on ClinicalTrials.gov